海尔生物2月2日获融资买入1721.44万元，融资余额2.45亿元

Group 1 - Haier Biomedical's stock dropped by 3.42% on February 2, with a trading volume of 113 million yuan. The financing buy amount was 17.21 million yuan, while the financing repayment was 23.61 million yuan, resulting in a net financing buy of -6.39 million yuan. The total financing and securities balance reached 247 million yuan [1] - The financing balance of Haier Biomedical on February 2 was 245 million yuan, accounting for 2.41% of the circulating market value, which is above the 50th percentile level over the past year, indicating a relatively high position [1] - On the same day, Haier Biomedical repaid 2,300 shares in securities lending and sold 48,700 shares, with a selling amount of 1.57 million yuan. The securities lending balance was 175.06 million yuan, exceeding the 90th percentile level over the past year, also indicating a high position [1] Group 2 - As of January 20, the number of shareholders of Haier Biomedical reached 14,000, an increase of 5.33%, while the average circulating shares per person decreased by 5.06% to 22,571 shares [2] - For the period from January to September 2025, Haier Biomedical reported an operating income of 1.76 billion yuan, a year-on-year decrease of 1.17%, and a net profit attributable to shareholders of 198 million yuan, down 35.83% year-on-year [2] - Since its A-share listing, Haier Biomedical has distributed a total of 788 million yuan in dividends, with 452 million yuan distributed in the last three years [3]